Revision history of "Development of a technological platform for the creation of SARS-COV-2 and neutralising preparations for other respiratory viruses from hyperimmunised cow colostrum (BioMask)" (Q3069478)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

10 October 2024

  • curprev 09:0909:09, 10 October 2024DG Regio talk contribs 48,340 bytes +15 Changed label, description and/or aliases in pt
  • curprev 09:0909:09, 10 October 2024DG Regio talk contribs 48,325 bytes +1 Set a claim value: summary (P836): A Icosagen Cell Factory OÜ e a empresa parceira Science e Tegu OÜ estão a desenvolver tecnologias para criar soluções de anticorpos contra os vírus SARS-COV-2 e influenza A e B. As soluções de anticorpos são preparadas utilizando colostro de vaca hiperimunizado do qual podem ser removidos anticorpos neutralizantes. As soluções de anticorpos podem ser utilizadas para preparar preparações profiláticas por pulverização contra vários vírus respiratórios.

7 March 2024

6 November 2023

20 June 2023

12 June 2023

3 August 2022

  • curprev 21:0921:09, 3 August 2022DG Regio talk contribs 46,205 bytes +28,459 Changed label, description and/or aliases in lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv, nl, et, fr, de, it, es, and other parts: Adding translations: lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, pt, da, ro, sv,

13 January 2022

12 January 2022

5 December 2021

30 November 2021

  • curprev 14:2214:22, 30 November 2021DG Regio talk contribs 13,205 bytes +1,269 Created claim: summary (P836): Icosagen Cell Factory OÜ und Partnerunternehmen Science und Tegu OÜ entwickeln Technologien zur Entwicklung von Antikörperlösungen gegen SARS-COV-2 und Influenza-A- und B-Viren. Antikörperlösungen werden mit hyperimmunisiertem Kuhkolostrum vorbereitet, aus dem neutralisierende Antikörper entfernt werden können. Antikörperlösungen können verwendet werden, um Spray prophylaktische Präparate gegen verschiedene Atemviren vorzubereiten., translated_s...
  • curprev 14:2214:22, 30 November 2021DG Regio talk contribs 11,936 bytes +241 Changed label, description and/or aliases in de: translated_label

26 November 2021

  • curprev 06:3006:30, 26 November 2021DG Regio talk contribs 11,695 bytes +1,319 Created claim: summary (P836): Icosagen Cell Factory OÜ et la société partenaire Science et Tegu OÜ développent des technologies pour créer des solutions d’anticorps contre les virus SARS-COV-2 et la grippe A et B. Les solutions d’anticorps sont préparées à l’aide de colostrum de vache hyperimmunisé dont les anticorps neutralisants peuvent être retirés. Des solutions d’anticorps peuvent être utilisées pour préparer des préparations prophylactiques de pulvérisation contre dive...
  • curprev 06:3006:30, 26 November 2021DG Regio talk contribs 10,376 bytes +259 Changed label, description and/or aliases in fr: translated_label

18 August 2021

16 August 2021